Emerging epigenomic landscapes of pancreatic cancer in the era of precision medicine
In pancreatic cancer, the epigenomic landscape can strongly impact the disease phenotype. Here, the authors discuss recent advances in our understanding of pancreatic cancer epigenomics, and how this knowledge can integrate with precision medicine approaches in this lethal disease.
Saved in:
Main Authors: | Gwen Lomberk, Nelson Dusetti, Juan Iovanna, Raul Urrutia |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2019
|
Subjects: | |
Online Access: | https://doaj.org/article/0784c10024e34076bcbf2a0a39e6dc2f |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Distinct epigenetic landscapes underlie the pathobiology of pancreatic cancer subtypes
by: Gwen Lomberk, et al.
Published: (2018) -
Collateral Victim or Rescue Worker?—The Role of Histone Methyltransferases in DNA Damage Repair and Their Targeting for Therapeutic Opportunities in Cancer
by: Lishu He, et al.
Published: (2021) -
Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: Role of the Radiologist and Oncologist in the Era of Precision Medicine
by: Federica Vernuccio, et al.
Published: (2021) -
Precision cancer therapy is impacted by oncogene-dependent epigenome remodeling
by: Feng Liu, et al.
Published: (2017) -
Artificial intelligence for assisting cancer diagnosis and treatment in the era of precision medicine
by: Zi‐Hang Chen, et al.
Published: (2021)